INITIAL RESULTS OF THE RE-VERSE AD TRIAL: IDARUCIZUMAB REVERSES THE ANTICOAGULANT EFFECTS OF DABIGATRAN IN PATIENTS IN AN EMERGENCY SETTING OF MAJOR BLEEDING, URGENT SURGERY OR INTERVENTIONS
C Pollack, J Eikelboom, J Weitz, P Reilly, S Glund, R Dubiel, J Kreuzer, J Stangier, B Wang, J Gagg, P Verhamme, R Bernstein, M Huisman, E Hylek, P Kamphuisen, J Levy, F Selke, T Steiner, C Kam
Emergency Medicine Journal Dec 2015, 32 (12) 979-980; DOI: 10.1136/emermed-2015-205372.9